Explore more publications!

Today in New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in New York.

Press releases published on November 16, 2025

Vansilk Home Unveils 2025 Winter Bedding Collection: Embrace Warmth, Softness, and Superior Sleep
Todd J. Stein’s The Final Fight Enters Fundraising Phase
Heinz H. Bartesch’s ‘Take It Where You Find It’ Tells a Powerful Story of Survival and the American Dream
The Showcase Tour Is Redefining Touring for Independent Artists by Partnering With Global Superstars
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
African Fashion Council Student Showcase, Curated by Chuks Collins, Highlights the Next Generation of Diaspora Designers
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
KBR DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action Commenced by the Firm – KBR
MRX DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX
FLYY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spirit Aviation Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Class Action Reminder for JHX Investors: Kessler Topaz Meltzer & Check, LLP Reminds James Hardie Industries plc (JHX) Investors of Securities Fraud Class Action Lawsuit
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions